Condition: Osteonecrosis Due to Drugs, Jaw · Sponsor: Centre Hospitalier Universitaire de Besancon
This study aims to demonstrate, during the first standard surgical management of patients with stage II MRONJ, the effect of the implantation of a cryopreserved hAM on the maxillomandibular bone, on the healing of the oral mucosa.
This description comes directly from the study's public registry record.
Florelle GINDRAUX, PhD · 033381218998 · fgindraux@chu-besancon.fr
Always discuss trial participation with your own doctor first.
| CHU de Besancon | Besançon, France | Recruiting |
| CHU Bordeaux Pellegrin | Bordeaux, France | Not Yet Recruiting |
| CHU de Dijon | Dijon, France | Not Yet Recruiting |
| CHR Metz Thionville | Metz, France | Not Yet Recruiting |
| CHU de Reims | Reims, France | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05664815